Kim, D. W., Ponto, L., Pereira, A. A. L., Kim, R. D., Kracht, C., Lauwers, G., Pimiento, J. M., Castria, T. B. D., Strosberg, J. R., Haider, M., Imanirad, I., Avriett, T. A., Costello, J., Hoffe, S. E., Chen, D., Mukherjee, S., Mehta, R. (2025). A phase II study of neratinib (Nera) in combination with chemotherapy/trastuzumab/pembrolizumab (C/T/P) in HER2 overexpressing gastroesophageal cancers (GECs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps514